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Abstract Contact force (CF) is one of the major determinants
for sufficient lesion formation. CF-guided procedures are
associated with enhanced lesion formation and procedural
success. We report our initial experience in epicardial ventric-
ular tachycardia (VT) ablation with a force-sensing catheter
using a new approach with an angioplasty balloon. Two
patients with arrhythmogenic right ventricular cardiomyopa-
thy who underwent prior unsuccessful endocardial ablation
were treated with epicardial VTablation. CF data were used to
titrate force, power and ablation time.
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Introduction
An epicardial approach for ablation of ventricular tachycardia
(VT) is often required, since the substrate cannot always be
reached entirely from the endocardium [1–3]. Particularly in
patients diagnosed with arrhythmogenic right ventricular dys-
plasia (ARVC) an epicardial ablation approach is frequently
inevitable [4]. Radiofrequency (RF) catheter ablation in the
epicardial space is substantially different from endocardial
ablation. First of all, there is the absence of circulating blood
in the epicardium and therefore lack of convective cooling
during ablation, the catheter orientation is usually different,
and the varying presence of epicardial adipose tissue interferes
with lesion formation [5, 6]. These factors all have significant
influence on RF lesion formation and should be taken into
account during epicardial VT ablation. A European study
demonstrated that the overall success rate of epicardial abla-
tion for different aetiologies is 71.6 % [7]. However, during
follow-up a significant proportion of 31.4 % experienced
recurrence of the tachycardia. In the past, several techniques
were developed to improve energy delivery in the epicardial
space. Cooled-tip ablation proved to be superior to standard
ablation and bipolar ablation resulted in more effective energy
delivery than unipolar ablation [8, 9]. In order to further
increase the efficacy of epicardial ablation, CF-sensing cath-
eters may play a role.
Contact force (CF) is a very important determinant of
lesion formation [10, 11]. Since effective lesion formation in
the epicardium can be challenging, we hypothesised that the
use of a CF-sensing catheter might contribute to efficacy and
safety during epicardial RF ablation. The aim of this paper is
to report our initial experience and demonstrate the CF-guided
epicardial approach and its feasibility for epicardial VT abla-
tion. This report describes two patients with ARVC who had
undergone prior unsuccessful endocardial ablation and were
referred for epicardial ablation of VT.
Methods
Before the procedure, the patients were informed about the
epicardial approach and written informed consent was obtain-
ed from both patients prior to the procedure. The procedures
were performed under general anaesthesia with a cardiotho-
racic surgical team on standby during the entire intervention.
After the procedure a pericardial drain (PeriVac pericardial
L. Dabiri Abkenari : F. Akca : T. Szili-Torok
Clinical Electrophysiology, Department of Cardiology, ErasmusMC,
Rotterdam, the Netherlands
N. M. Van Mieghem
Interventional Cardiology, Department of Cardiology, Erasmus MC,
Rotterdam, the Netherlands
T. Szili-Torok (*)
Thoraxcenter, Department of Clinical Electrophysiology, Erasmus
MC, PO Box 2040, 3000 CA Rotterdam, the Netherlands
e-mail: t.szilitorok@erasmusmc.nl
Neth Heart J (2014) 22:225–230
DOI 10.1007/s12471-014-0554-8
tray) remained in place for 8–12 h if no significant bleeding or
fluid drainage occurred.
Epicardial access
Percutaneous epicardial access was obtained from a
subxyphoid level. This was performed with a Tuohy needle
(18G, length 15 cm) and a 9 Fr, 24 cm Arrow flex sheath. The
pericardial puncture was fluoroscopy guided with the X-ray C
arm at 90° latero-lateral projection. Continuous, intermittent
small amounts of iodine-based contrast were injected, until the
typical layering of the epicardial space was seen (Fig. 1a) [12].
A guide wire (Cordis Exchange wire 35”) was introduced via
the needle. Afterwards the soft flexible vascular sheath (9 Fr)
was inserted using the Seldinger technique to manipulate the
ablation catheter in the pericardium (Fig. 1b).
CF-sensing catheter
An open irrigated-tip RF catheter with CF sensing technology
(TactiCath®, Endosense SA, Geneva, Switzerland) was used.
This catheter integrates a CF sensor at the distal part of an RF
open-irrigated catheter between the second and third electrode
[13]. The force sensor has a deformable body and makes use
of infrared laser light and three optical fibres (diameter of
0.125 mm) to detect deformations, which are related to the
amount of force applied to the catheter tip [10]. The sensor is
able to measure the lateral and axial forces distinctly. The
system displays both magnitude and angle of the CF vector
with intervals of 100 ms on a separate screen during the
ablation procedure. The amount of CF is expressed in grams,
and the integrated software calculates a Force-Time Integral™
(FTI, function of force and time, expressed in g) [11].
Mapping and ablation
Both groins were prepared for percutaneous punctures. The
chest and abdomen around the xyphoid process were prepared
and isolated. A 6 Fr sheath was inserted to gain right femoral
venous access for standard diagnostic EP catheters. A
quadripolar electrode was placed into the right ventricular
(RV) apex to serve as a reference for the electroanatomical
Fig. 1 Fluoroscopic recordings
during the ablation procedure.
a Catheter placed in the right
ventricle and coronary sinus with
contrast fluid visible in the
pericardial space. b Through the
soft flexible vascular sheath, the
CF sensing ablation catheter is
inserted into the pericardium.
c Introduction of an additional
catheter through the same sheath
from the CF catheter.
d Introduction of the angioplasty
balloon in the pericardial space.
* Quadripolar catheter into the
RVapex. ∇ diagnostic catheter
placed in the coronary sinus.
★ CF sensing ablation catheter.
✚ Additional catheter into the
pericardium. O Angioplasty
balloon advanced into the
pericardium
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mapping system (EAM). Three-dimensional EAM was per-
formed using the NavX™ Velocity system (St Jude, St Paul,
MN, USA). Endocardial and epicardial bipolar voltage maps
were made. Scar tissue was defined as local bipolar electro-
grams <0.5 mV. Low voltages associated with high-frequency
late components were considered as scar area and this was
used to create a voltage map. A selective coronary angiogram
was performed before power delivery to the epicardial tissue
in order to evaluate the proximity to the coronary arteries.
Calibration of CF catheter
For precise CF measurement, calibration in a no-contact po-
sition is required. This was achieved by introduction of an
additional catheter together with an angioplasty balloon
(5x15 mm compliant Trek coronary dilatation catheter™,
Abbott Vascular, Santa Clara, USA) through the same sheath
(Fig. 1c). The CF catheter is 7 F sheath compatible, making
simultaneous introduction of the two catheters possible in the
9 F sheath. The balloon was inflated at 10 Atm just beyond the
tip of the catheter in the pericardium (Fig. 1d). Calibration was
performed in a single position where the inflated balloon and
the ablation catheter tip could be adjacent in a linear fashion.
During inflation, the calibration was carried out and the bal-
loon was removed for the rest of the procedure. Dynamic CF
data were used to guide the manipulation of the catheter for
mapping and RF delivery epicardially.
Case presentation
Case 1
A 67-year-old man diagnosed with ARVC and a preserved
systolic left ventricular function presented with multiple epi-
sodes of very symptomatic non-sustained VT, which was
refractory to medical therapy (Fig. 2a). The VTs had a typical
morphology indicating an origin from the right outflow re-
gion. The patient had a single chamber defibrillator.
Endocardial ablation had been attempted twice (1 year and
3 years previously) and failed to eliminate the substrate of the
VTs. An epicardial origin was suspected on the basis of
mapping during the endocardial procedure.
During mapping, extensive anterior right ventricular out-
flow tract (RVOT) epicardial scarring was identified. Other
RV regions had no low bipolar voltages. Scar homogenisation
was performed endocardially as well as in the adjacent epi-
cardial sites. This led to complete diminution of the premature
ventricular contractions, and non-inducibility of VTs during a
30-min waiting period.
The CF remained under 25 g throughout the whole epicar-
dial mapping procedure. In some regions it was very challeng-
ing to increase the contact force above 2 g. A total number of 6
RF applications (power: 30–45 W, time: 60 s, irrigation flow
>17 mL/min) were applied epicardially. The average force
during the ablations was 9 g, with an average FTI of 418 g.
In total 33 min of fluoroscopy were used. No audible steam
pop was observed during applications. No complications
occurred.
After 1 year of follow-up the patient was free from symp-
toms and ICD interrogation detected no more ventricular
arrhythmias. No antiarrhythmic drugs were used during
follow-up.
Case 2
A 48-year-old man, previously a top level sporter, was re-
ferred because of incessant VT. Sinus rhythmwas obtained by
electrical cardioversion. Interestingly enough he had previ-
ously undergone RF ablation for idiopathic RVOT tachycar-
dia. The first episode had occurred 16 years ago. He was
initially treated with beta-blocker therapy, and remained
asymptomatic for 16 years without medication until he pre-
sented with haemodynamically stable VTs. After further in-
vestigations he was diagnosed with ARVC. This clinical VT
was basically different than the one described 16 years ago.
Fig. 2 12-lead ECG displaying non-sustained VT with a left bundle
branch block morphology and inferior axis, suggestive for RVOT origin
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During the procedure two distinct VTs (cycle length
370 ms and 330 ms) with left bundle branch block morphol-
ogy, left axis and initial slurring in the QRS complex were
reproducibly induced by programmed ventricular stimulation.
Epicardial mapping identified their origin in the apical region
of the right ventricle, where dense scar bordered healthy
tissue. A linear epicardial line of ablation was drawn from
the border of the scar to the healthy tissue (Fig. 3a). The VT
terminated during the third ablation point (Fig. 3b). The
tachycardia was no longer inducible after ablation, even after
a 30-min waiting period.
The average CF was 6 g, and remained under 17 g during
the entire mapping procedure. A total number of 14 RF
applications (power: 30–45 W, time: 60 s, irrigation flow:
20 ml/min) were applied epicardially. The average FTI was
150 g per ablation point (maximum 476 g). In total 34 min of
fluoroscopy were used. No audible steam pop was observed
during the applications. No complications occurred. The pa-
tient remains free of symptoms at 6 months of follow-up.
Discussion
Importance of contact force
Previous research demonstrated that CF is a major determi-
nant for lesion formation and has a greater effect on lesion size
than RF output power [10]. CF appears to be associated with
FTI, lesion size, and procedural success [10, 11, 14]. Research
on pulmonary vein isolation for atrial fibrillation (AF)
revealed that the rate of recurrence was associated with the
percentage of ablations with very low CFs (<10 g) and pre-
dicts recurrence at 12 months. All AF patients who were
treated with an average CF of <10 g experienced recurrences,
whereas 80 % of the patients treated with a CF of >20 g
experienced no AF recurrences [15]. These data demonstrate
that proper catheter-tissue contact is crucial to establish ap-
propriate lesions and avoid conduction recovery [13, 15, 16].
Previously only surrogate information regarding CF was
available during ablation procedures such as tactile feedback,
movement of the catheter tip on fluoroscopy, ST elevation in
the unipolar electrogram and impedance monitoring [17, 18].
However, these criteria seemed to be inadequate for estimat-
ing real-time CF. [17, 18] Kuck et al. [14] demonstrated that
tactile feedback during mapping and ablation is not a reliable
parameter and dangerous forces could be applied during cath-
eter manipulation. Furthermore, Kumar et al. [18] found that
impedance fall with ablation only has modest predictive value
for CF and FTI, and could not accurately differentiate between
low and high CFs. Currently, catheters are available that
provide direct and continuous feedback regarding CF. The
use of this type of catheter has been associated with a decrease
in the number of RF applications, which does not result in
lesion formation because of insufficient CF [5].
Another important issue during catheter ablation is inter-
mittent CF due to the continuous movements of the heart and
respiratory movements. This may occur if the catheter is not in
constant contact with the myocardium. This leads to impaired
energy delivery and subsequently inferior lesion formation
[15]. Reddy et al. showed a strong correlation between low
Fig. 3 a Electroanatomical map from Case 2 after ablation. Sites
where RF applications were applied are indicated by red dots.
Ablation was performed along the borders of the scar region
(marked by grey coloration). b Intra-cardiac electrograms at the
successful ablation site showing late potentials (fragmented poten-
tials occurring after the end of surface QRS complex) recorded by
the ablation catheter. During ablation termination of the tachycar-
dia occurred
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CF and intermittent catheter-tissue contact. Continuous CF
feedback allows the operator to adapt the CF during applica-
tions, therefore improving lesion quality. However, in some
regions it is difficult to achieve a good and stable catheter
position with sufficient CF, as we experienced as well during
our ablation procedures. Shah et al. [11] demonstrated that FTI
is strongly and linearly correlated with lesion depth and vol-
ume. Therefore, the operator could compensate low CF by
varying RF power and duration of an application.
Specific concerns during epicardial ablation
Circumstances for catheter ablation on the epicardium are
substantially different from endocardial ablation. The absence
of a heat sink effect (no circulating blood) results in larger
lesions on the epicardium, even though the FTI is twice as low
compared with endocardial applications [5]. In the endocardi-
um a CF <10 g or FTI <500 g would lead to non-identifiable
lesions on the myocardium. The results from Sacher et al.
demonstrate that this was not the case for the epicardium.
Wong et al. [6] report that for each doubling of tissue contact
between 5 g and 40 g of CF, there is a corresponding doubling
in absolute lesion formation and point out the advantage of CF
sensing during the ablation. Nevertheless, on the epicardium
sufficient lesion formation will occur at lower CF and power
output than endocardially. Furthermore, the parallel catheter
orientation with lower axial CF compared with endocardial
ablation creates more broad and shallow lesions [19]. Using
an epicardial approach, complete transmural lesions could be
created in the right ventricle (because of the thinner myocar-
dium) [6]. However, for ablation at sites with a thicker myo-
cardial wall a combined endo-epicardial approach could be
necessary to achieve transmural lesions.
During ablation, an obstacle for the energy transmission to
the epicardium is often the presence of epicardial fat. The low
electrical and thermal conductive properties reduce the trans-
mission of energy to the underlying tissue. When ablating at
sites with a thick layer of adipose tissue, a high CF is required
to achieve at least minimal lesion formation [6]. At sites with
epicardial fat of >5 mm, epicardial lesion depth was 1–2 mm
when high CF ablation was performed. For ablation at these
specific sites, the CF-sensing catheter might have benefits in
order to create clinically significant lesions. However, further
clinical studies are needed to investigate this issue.
Calibration of catheter
During endocardial procedures the CF reference (‘no
electrode-tissue contact’) is set when the catheter is floating
in the heart chamber and can be verified during the procedure.
Calibration is thus a crucial part of reliably, or at least rela-
tively, measuring contact force. We describe the first cases in
which a non-contact reference in the epicardiumwas achieved
by using an inflated angioplasty balloon (visually beyond the
borders of the catheter tip) in an attempt to minimise tissue
contact. In this setting the non-contact and subsequent mea-
surements were not considered as absolute values but as an
indication of relative force, as the ‘zero’ is set by the operator.
In the animal study by Wong et al. [6] normal saline was
introduced into the pericardial space to allow catheter floating
and therefore zero calibration of CF. However, we assume that
the advantages of the angioplasty balloon might be the other-
wise compromising haemodynamics. The infusion of saline
into the pericardial space could cause tamponade symptoms.
This is especially important in patients with a decreased left
ventricular function. However, more clinical experience is
necessary to evaluate the use of different epicardial calibration
methods.
Safety
Epicardial approach as a first-line treatment of VT has been
increasingly used (35.8 %) [7]. Sacher et al. [20] performed a
multi-centre study on epicardial VT ablation and demonstrat-
ed that major complications could occur during and after the
procedure. Although recent techniques are developed to min-
imise these complications as much as possible, careful evalu-
ation is necessary for the correct approach to ablation, which
has been described previously [21–23].
As this paper describes the importance of good CF during
ablation for appropriate lesion formation, high CF values
could have serious implications regarding procedural safety.
Excessive CF values may result in complications such as
myocardial perforation, steam pop, cavitation, thrombus for-
mation, oesophageal injury, lung lesions and coronary artery
and phrenic nerve damage [5, 13, 24]. It is important that the
vector of force is pointing towards the myocardium to prevent
pulmonary lesions [5]. As it has been reported that CF infor-
mation at the epicardial side may not be as useful as
endocardially, the CF-sensing catheter could contribute to
visualising the vector of the force and therefore energy deliv-
ery. Furthermore, Wong et al. [6] described the impact of
applied CF and phrenic nerve (PN) injury. Although it is an
uncommon complication during epicardial ablation, their re-
sults demonstrated that PN injury occurs with increasing,
directly applied CF. At 5 or 10 g of CF, PN injury appeared
to be unlikely, but was practically universal when 20 g of force
was applied.
Conclusion
We report the first epicardial CF-guided VT ablation in
humans with the use of an angioplasty balloon for CF calibra-
tion. The information provided on CF could be useful to create
more accurate electroanatomical maps, produce better
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transmural lesions and avoid inefficient ablation points.
Although our limited initial experience was successful and
safe, more clinical evidence is required to demonstrate the
efficacy and safety of CF-guided epicardial VT ablation.
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